Who we are

BioCurate is a bold, collaborative venture, dedicated to translating Australian medical research and delivering health and economic benefits to the world. Created jointly by two of Australia’s leading biomedical universities, the University of Melbourne and Monash University, we are operationally independent with an absolute commitment to rigorous science and partnering closely with researchers to help conquer the challenges which stand between great ideas and global impact. We can help you change the future.

We bridge the gap

Our collaborative team of global biomedical experts bridge the gap between:

Academia + Industry
Ideas + Impact
Discovery + Partnerships
Collaboration + Commercialisation
Research + Translation

What we are doing

Staff profiles

Our team

150
Has over 150 years of combined biotech/pharma industry experience

35
Has been directly involved in over 35 Investigational New Drug applications (INDs)

70
Are responsible for 70 therapeutics currently in the clinic

$2.1B
Were directly involved in 15 deals worth a cumulative total of over $2.1 billion

Twitter feed

BioCurate Director of Project Management Dr Cathy Drinkwater will be a judge at the #AusBio20 Early Stage Investment Forum on 30 October. https://www.ausbiotechnc.org/early-stage-investment-forum @AusBiotech

BioCurate would like to congratulate Prof Andrew Wilks on his election as a Fellow of @AAHMS_health! We are delighted to see Andrew's contributions to cancer drug development in both academia and industry recognised.

Need #tech in your research? Don't miss: Part 2 @Bio21Institute 101 Platform Technology Series! Magnetic Resonance; @MetabolomicsAus; Protein Characterisation & Systems Computational Biology 11am-12pm; 2 - 3pm, 6th-13th Nov @AusBiotech @biomelb @BioCurate https://bit.ly/2SQOSaq

Join us at #AusBio20 as we exhibit with the Victorian Government this year. We look forward to meeting with industry leaders online for this year’s virtual event. @AusBiotech